Today’s Medical Development: Anatomy of an M&A Deal - From Analysis to Valuation
Hear MedWorld Advisors CEO Florence Joffroy-Black and Managing Director Dave Sheppard as they answer the question "What is the likely valuation of a business and what does it take to sell it?". From the start all the way to the transaction, listen as they walk you through the M&A process with a healthcare industry focus.
MedTech M&A Series: A Financial Buyer’s Perspective
Listen to Daniel Sheppard’s conversation with Eric Tansky, General Partner at Accelmed, Mike Magliochetti, PhD, Operating Partner at Riverside Partners, and Steve Sandbo, Principal at Vance Street Capital. In this installment, Dan covers everything from deal origination to transaction structure, as well as the MedTech/Healhcare M&A space as a whole from a private equity perspective.
MedWorld Advisors Plays a Key Role in Fighting Corona Virus
MedWorld Advisors plays a key role in fighting Corona Virus. In 2020 We were pleased and honored to announce the Strategic Alliance between Airon USA and GE as part of the current fight against the Corona Virus.
MedWorld Advisors Named #6 on Axial’s Top 20 Lower Middle Market Investment Banks
MedWorld Advisors is pleased to announce that we have been named #6 on Axial’s Q2 2021 Top 20 Lower Middle Market Investment Banks!
MedWorld Advisors @ MPO Summit 2021
MedWorld Advisors recaps the MPO (Medical Product Outsourcing) Summit 2021 in Salt Lake City, UT.
MedWorld Advisors @ AAOS 2021
MedWorld Advisors recaps the AAOS (American Academy of Orthopedic Surgeons) Conference in San Diego, CA.
MedTech M&A Series: A Strategic Buyer’s Perspective
Listen to Co-Founder and Managing Director Dave Sheppard’s conversation with Charlie Attlan of Boston Scientific, Eric Knudsen of ZOLL Medical and Tom Gales of Draeger. Part of our MedTech M&A Series, the panel for A Strategic Buyer’s Perspective discussed everything from how M&A strategy fits into their respective companies to deal origination and structure.
MedWorld Advisors @ MD&M West 2021
MedWorld Advisors recaps MD&M West (Medical Design and Manufacturing) 2021.
MedWorld Advisors @ HIMSS 2021
MedWorld Advisors recaps HIMSS (The Healthcare Information and Management Systems Society) 2021.
How an Idea Reaches Strategic Buyers
At a recent panel hosted by MedWorld’s Dave Sheppard, three MedTech Executives provided insight into how business ideas are relayed up the chain of command. To ensure that deals are made efficiently, it’s important that buying and selling companies understand each other’s corporate strategies during the earliest stages of business development.
Getting a Medical Device Strategic Buyer’s Attention
Managing Director Daniel Sheppard joined MDG Premium with his wife Shannon for a Q&A session covering things from the role MedWorld Advisors plays in the development of early-stage companies to when along the process it’s advantageous to bring an advisory team on board. A group of medical device entrepreneurs then joined to discuss their own journeys and pose questions.
10x Medical Device Conference: Interview with Daniel Sheppard
At the 10x Medical Device Conference, where the medical device ecosystem comes together to learn from and network with each other, host Joe Hage interviewed Managing Director Daniel Sheppard. Their conversation included what an ideal company looks like, how to prepare a company for a deal, developing commercialization strategies and more.
Valuing a MedTech Business
Some of the most common questions we’re asked relate to business valuation. While a one-size-fits-all answer doesn’t exist, there are some general guidelines that can be referenced. CEO Florence Joffroy-Black and Managing Director Dave Sheppard discussed key factors that affect the value of your business in a recent article for Today’s Medical Developments Magazine.
A Strategic Buyer’s Perspective: Quick Hits
Tactics, processes, relationships, timing – the panelists at our first MedTech M&A Series event in partnership with MassMEDIC spoke about these and more from a strategic buyer’s perspective. Executives from Boston Scientific, ZOLL Medical and Draeger sat down (virtually) with MedWorld Advisors’ own Dave Sheppard to share their experiences being at the helm of acquisition activity for their respective companies. Here’s a quick look at some of the main discussion points.
Why MedTech Businesses Are Looking to Sell Now
The medtech M&A market is running hot right now, and for many reasons, it’s a seller’s market. CEO Florence Joffroy-Black and Managing Director Dave Sheppard discussed why right now is great time for medtech companies looking to sell in a recent column for Medical Product Outsourcing Magazine.
Exit Strategy – When to Buy, Sell, Hold, Etc.
With steady M&A activity in the medtech sector, many are wondering — is now is a good time to sell a medtech company? Every business situation is unique, but MedWorld Advisors CEO Florence Joffroy-Black and Managing Director Dave Sheppard discussed some possible scenarios in a recent article published in Today’s Medical Developments Magazine.
Medical Device M&A Activity in 2021 – a Very Active Start to the Year
Activity in the medical device and medtech realms has been picking up steam throughout 2021. Many factors play into the continued growth we see, and the industry looks to keep moving forward. Extra cash on hand lends itself to M&A activity, and industry players are continuing to capitalize on opportunities.
MedTech’s Fit With The Digital Health Niche
The digital health trend has continued to accelerate throughout the global pandemic. Virtual consultations and the transition to telehealth has transformed the state of healthcare as we know it, and this looks likely to only pick up speed in the coming years ahead.
To The Daily Winners In Our Industry…..
Moving forward in 2021 in the medtech industry brings a true appreciation for everyone involved. Whether you are designing products, on the production line, or in the C-suite, you are making a difference every day and we applaud you. It’s not easy to succeed in this business or survive for the long term.
Medtech’s New Normal - C-Suite Challenges
C-Suite Challenges in Medtech’s New Normal
Many of the usual C-Suite management topics that are key to organizational success will remain the same this year.
Contact us.
We love what we do as we partner with our clients to bring them success. There are often many approaches to achieve your goals and will help you be successful. The best thing about our services is that YOU decide what YOU want to engage us for.
Connect with us for further details.
contact@medworldadvisors.com
(805) 441-0962
153 Summer Street
Andover, MA 01810